199 related articles for article (PubMed ID: 28683198)
21. Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
Milenic DE; Wong KJ; Baidoo KE; Nayak TK; Regino CA; Garmestani K; Brechbiel MW
MAbs; 2010; 2(5):550-64. PubMed ID: 20716957
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Photochemical Studies on Gallium and Indium Complexes of DTPA-PEG
Gut M; Holland JP
Inorg Chem; 2019 Sep; 58(18):12302-12310. PubMed ID: 31522510
[TBL] [Abstract][Full Text] [Related]
23. Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.
Shin IS; Lee SM; Kim HS; Yao Z; Regino C; Sato N; Cheng KT; Hassan R; Campo MF; Albone EF; Choyke PL; Pastan I; Paik CH
Nucl Med Biol; 2011 Nov; 38(8):1119-27. PubMed ID: 21741258
[TBL] [Abstract][Full Text] [Related]
24. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Price EW; Zeglis BM; Lewis JS; Adam MJ; Orvig C
Dalton Trans; 2014 Jan; 43(1):119-31. PubMed ID: 24104523
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
[TBL] [Abstract][Full Text] [Related]
26. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
27. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP
Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001
[TBL] [Abstract][Full Text] [Related]
28. Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):979-991. PubMed ID: 31993928
[TBL] [Abstract][Full Text] [Related]
29. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
30. Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.
Paterson BM; Buncic G; McInnes LE; Roselt P; Cullinane C; Binns DS; Jeffery CM; Price RI; Hicks RJ; Donnelly PS
Dalton Trans; 2015 Mar; 44(11):4901-9. PubMed ID: 25351329
[TBL] [Abstract][Full Text] [Related]
31. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
[TBL] [Abstract][Full Text] [Related]
32. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
Price EW; Zeglis BM; Cawthray JF; Ramogida CF; Ramos N; Lewis JS; Adam MJ; Orvig C
J Am Chem Soc; 2013 Aug; 135(34):12707-21. PubMed ID: 23901833
[TBL] [Abstract][Full Text] [Related]
33. Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine.
Rigby A; Firth G; Rivas C; Pham T; Kim J; Phanopoulos A; Wharton L; Ingham A; Li L; Ma MT; Orvig C; Blower PJ; Terry SYA; Abbate V
Bioconjug Chem; 2022 Jul; 33(7):1422-1436. PubMed ID: 35801668
[TBL] [Abstract][Full Text] [Related]
34. PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
Nayak TK; Garmestani K; Baidoo KE; Milenic DE; Brechbiel MW
Int J Cancer; 2011 Feb; 128(4):920-6. PubMed ID: 20473899
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
36. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
[TBL] [Abstract][Full Text] [Related]
37. H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals.
Ramogida CF; Cawthray JF; Boros E; Ferreira CL; Patrick BO; Adam MJ; Orvig C
Inorg Chem; 2015 Feb; 54(4):2017-31. PubMed ID: 25621728
[TBL] [Abstract][Full Text] [Related]
38. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.
Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ
Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of [
Pougoue Ketchemen J; Njotu FN; Babeker H; Ahenkorah S; Tikum AF; Nwangele E; Henning N; Cleeren F; Fonge H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2070-2084. PubMed ID: 38376808
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides.
Garmestani K; Yao Z; Zhang M; Wong K; Park CW; Pastan I; Carrasquillo JA; Brechbiel MW
Nucl Med Biol; 2001 May; 28(4):409-18. PubMed ID: 11395314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
